Physician

Ashley Sturgeon, MD

According to 2025 Medicare claims, Ashley Sturgeon, MD (NPI: 1285955492) practices dermatology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is DERMATOLOGY ASSOCIATES OF WEST TEXAS, LLP (NPI: 1679704530; TIN: 270615200) and primary practice location at 79410-1332.

Sturgeon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 761 traditional Medicare patients, billed 6,320 HCPCS/CPT codes, and received $383,327 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,092 prescription claims across 420 beneficiaries totaling $329,932 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 122 records totaling $3,345. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $89,114 to $383,327. Similarly, Part D prescription costs have moved sharply higher in recent years, from $20,691 to $329,932. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$192K$383K2015 Medicare payment: $89,114 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $114,127 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $89,734 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $183,774 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $251,547 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $288,812 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $214,487 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $307,536 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $373,182 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $383,327 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153622,029$89,114
20164732,731$114,127
20174282,684$89,734
20184752,791$183,774
20194813,383$251,547
20204832,750$288,812
20213822,083$214,487
20224904,310$307,536
20236215,927$373,182
20247616,320$383,327

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$165K$330K2015 Drug cost: $20,691 (USD; Tot_Drug_Cst)2016 Drug cost: $40,489 (USD; Tot_Drug_Cst)2017 Drug cost: $4,839 (USD; Tot_Drug_Cst)2018 Drug cost: $934 (USD; Tot_Drug_Cst)2019 Drug cost: $309 (USD; Tot_Drug_Cst)2020 Drug cost: $457 (USD; Tot_Drug_Cst)2022 Drug cost: $77,596 (USD; Tot_Drug_Cst)2023 Drug cost: $242,467 (USD; Tot_Drug_Cst)2024 Drug cost: $329,932 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201566142$20,691
201658122$40,489
201757120$4,839
20183748$934
20191114$309
20201119$457
2021N/RN/RN/R
2022262621$77,596
2023369939$242,467
20244201,092$329,932

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more220257$87
17110Destruction of skin growth, 1-14 growths306425$74
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more382575$64
17000Destruction of precancer skin growth, 1 growth411551$36
17003Destruction of precancer skin growth, 2-14 growths3362,303$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab22896$119,724
Clobetasol PropionateClobetasol Propionate912,400$3,099
HydrocortisoneHydrocortisone1153,188$1,906
FluorouracilFluorouracil27842$1,812
KetoconazoleKetoconazole1383,905$1,768

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.122$3,345ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ashley Sturgeon, MD?

Tedicare shows public-source Medicare data for Ashley Sturgeon, MD (NPI 1285955492), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashley Sturgeon, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ashley Sturgeon, MD?

Ashley Sturgeon, MD is linked to DERMATOLOGY ASSOCIATES OF WEST TEXAS, LLP (billing NPI 1679704530) in the available physician profile data.

Does Ashley Sturgeon, MD have Open Payments data?

Ashley Sturgeon, MD has 122 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.